Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Jones, S E
Vogel, C L
Wolter, J M
Plourde, P V
AffiliationM.D. Anderson Cancer Center, University of Texas, Houston, Department of Breast Medical Oncology 77030, USA. Aman__Buzdar@isqm.mda.uth.tmc.edu